跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVFRAXY 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EVFRAXY 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
EVFRAXY 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Biosimilar Collaborations Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 18, 2025
Approval ID
15549c16a09bfb79
Company
Biosimilar Collaborations Ireland Limited
Type
Standard
Approval Details
Approval Id
15549c16a09bfb79
Drug Cima Aemps Name
EVFRAXY 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number
1251946001
Holder Company Name
Biosimilar Collaborations Ireland Limited
Marketing Company Name
Biocon Biologics Spain, S.L.
Holder Company Detail Path
/organization/biosimilar-collaborations-ireland-ltd
Authorization Date
2025-09-18
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
60 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Biosimilar Collaborations Ireland Limited
Company Detail Path
/organization/biosimilar-collaborations-ireland-ltd
Company Information
Pharmaceutical Company Name
Biosimilar Collaborations Ireland Ltd.
Country Name
Ireland
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 18, 2025
Approval ID
15549c16a09bfb79
Type
Standard
Back to CIMA-AEMPS Approvals